(Q40241548)

18 September 2017

Empirical amphotericin B therapy on day 4 or day 8 of febrile neutropenia (English)

1 reference

18 September 2017

1 reference

Arunaloke Chakrabarti

6

object named as

Arunaloke Chakrabarti

1 reference

18 September 2017

Pankaj Malhotra

1

1 reference

18 September 2017

Akash Makkar

2

1 reference

18 September 2017

Guru Subramanian Guru Murthy

3

1 reference

18 September 2017

Neelam Varma

4

1 reference

18 September 2017

Subhash Varma

5

1 reference

18 September 2017

11 July 2013

1 reference

18 September 2017

1 reference

18 September 2017

57

1 reference

18 September 2017

2

1 reference

18 September 2017

110-115

1 reference

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

18 September 2017

1 reference

Empirical antifungal therapy

21 January 2018

1 reference

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

21 January 2018

1 reference

Fungal infections in cancer patients: an international autopsy survey.

21 January 2018

1 reference

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

21 January 2018

1 reference

The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.

21 January 2018

1 reference

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

21 January 2018

1 reference

Antifungal treatment strategies in high risk patients

21 January 2018

1 reference

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management

21 January 2018

1 reference

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.

21 January 2018

1 reference

Patients at high risk of invasive fungal infections: when and how to treat

21 January 2018

1 reference

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study

21 January 2018

1 reference

Mortality and costs of acute renal failure associated with amphotericin B therapy

21 January 2018

1 reference

Risk factors for Amphotericin B-associated nephrotoxicity

21 January 2018

1 reference

Amphotericin B use in a community hospital, with special emphasis on side effects

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/MYC.12108

1 reference

18 September 2017

1 reference